» Articles » PMID: 39288176

Hippo Effector, Yorkie, is a Tumor Suppressor in Select Squamous Epithelia

Overview
Specialty Science
Date 2024 Sep 17
PMID 39288176
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) and Yorkie (Yki) are transcription cofactors of the highly conserved Hippo signaling pathway. It has been long assumed that the YAP/TAZ/Yki signaling drives cell proliferation during organ growth. However, its instructive role in regulating developmentally programmed organ growth, if any, remains elusive. Out-of-context gain of YAP/TAZ/Yki signaling often turns oncogenic. Paradoxically, mechanically strained, and differentiated squamous epithelia display developmentally programmed constitutive nuclear YAP/TAZ/Yki signaling. The unknown, therefore, is how a growth-promoting YAP/TAZ/Yki signaling restricts proliferation in differentiated squamous epithelia. Here, we show that reminiscent of a tumor suppressor, Yki negatively regulates the cell growth-promoting PI3K/Akt/TOR signaling in the squamous epithelia of tubular organs. Thus, downregulation of Yki signaling in the squamous epithelium of the adult male accessory gland (MAG) up-regulates PI3K/Akt/TOR signaling, inducing cell hypertrophy, exit from their cell cycle arrest, and, finally, culminating in squamous cell carcinoma (SCC). Thus, blocking PI3K/Akt/TOR signaling arrests Yki loss-induced MAG-SCC. Further, MAG-SCCs, like other lethal carcinomas, secrete a cachectin, Impl2-the homolog of mammalian IGFBP7-inducing cachexia and shortening the lifespan of adult males. Moreover, in the squamous epithelium of other tubular organs, like the dorsal trunk of larval tracheal airways or adult Malpighian tubules, downregulation of Yki signaling triggers PI3K/Akt/TOR-induced cell hypertrophy. Our results reveal that Yki signaling plays an instructive, antiproliferative role in the squamous epithelia of tubular organs.

References
1.
Visvader J . Cells of origin in cancer. Nature. 2011; 469(7330):314-22. DOI: 10.1038/nature09781. View

2.
Beauchamp E, Platanias L . The evolution of the TOR pathway and its role in cancer. Oncogene. 2012; 32(34):3923-32. DOI: 10.1038/onc.2012.567. View

3.
Lane M, Sauer K, Wallace K, Jan Y, Lehner C, Vaessin H . Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell. 1996; 87(7):1225-35. DOI: 10.1016/s0092-8674(00)81818-8. View

4.
Heifetz Y, Lung O, Frongillo Jr E, Wolfner M . The Drosophila seminal fluid protein Acp26Aa stimulates release of oocytes by the ovary. Curr Biol. 2000; 10(2):99-102. DOI: 10.1016/s0960-9822(00)00288-8. View

5.
Wallrath L, Burnett J, Friedman T . Molecular characterization of the Drosophila melanogaster urate oxidase gene, an ecdysone-repressible gene expressed only in the malpighian tubules. Mol Cell Biol. 1990; 10(10):5114-27. PMC: 361181. DOI: 10.1128/mcb.10.10.5114-5127.1990. View